VTRO (Vitro Biopharma) Total Operating Expense: $7.76 Mil (TTM As of Oct. 2022)


What is Vitro Biopharma Total Operating Expense?

Vitro Biopharma VTRO Total Operating Expense is $7.76 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's Total Operating Expense for the three months ended in Oct. 2022 was $7.76 Mil. Vitro Biopharma's Total Operating Expense for the trailing twelve months (TTM) ended in Oct. 2022 was $7.76 Mil.

Vitro Biopharma Total Operating Expense Related Terms

Vitro Biopharma Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Total Operating Expense Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.24 0.45 5.08 7.76

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.24 0.45 5.08 7.76

Vitro Biopharma Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $7.76 Mil mean?
Vitro Biopharma (VTRO) has a Total Operating Expense of $7.76 Mil as of Oct. 2022. Total operating expense is the primary recurring expense associated with central operations. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's Total Operating Expense too high?
Vitro Biopharma's current Total Operating Expense is $7.76 Mil.
How does Vitro Biopharma's Total Operating Expense compare to ?
Vitro Biopharma's Total Operating Expense of $7.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current Total Operating Expense is $7.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Total Operating Expense of $7.76 Mil. The current Total Operating Expense is $7.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Total Operating Expense is $7.76 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.